Cancer BiologyInternational Journal of CancerPeer-reviewed
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade
Bardees M. Foda, Sean A. Misek, Kathleen A. Gallo, Richard R. Neubig
This study shows that inhibiting the Rho/MRTF pathway with CCG-257081 enhances the effectiveness of PD1/PDL1 blockade in BRAF-resistant melanoma.
4 citations